Arginase Inhibition in Humans With Obesity

Status:
Completed

Trial end date:
2022-03-01

Target enrollment:

Participant gender:

To evaluate the efficacy of arginase inhibition on endothelial function in humans with obesity.

Early Phase 1

Karolinska Institutet